Identification of genes differentially expressed in glioblastoma versus pilocytic astrocytoma using Suppression Subtractive Hybridization

Oncogene

Volumn 25, Issue 19, 2006, Pages 2818-2826

  Colin, C ^a   Baeza, N ^a   Bartoli, C ^a   Fina, F ^b   Eudes, N ^a   Nanni, ^b   Martin, P M ^b,c   Ouafik, L ^c   Figarella Branger, D ^a,d  

^a AIX MARSEILLE UNIVERSITY   (France)

^b ASSISTANCE PUBLIQUE HÔPITAUX DE MARSEILLE   (France)

^c INSERM   (France)

^d TIMONE HOSPITAL   (France)

Author keywords

Fibronectin; Human gliomas; Real time quantitative RT PCR; SPOCK1; SSH (Suppression Subtractive Hybridization)

Indexed keywords

APOLIPOPROTEIN D; CHITINASE; CHITINASE 3 LIKE 1 PROTEIN; ELONGATION FACTOR 1; FIBRONECTIN; KERATOEPITHELIN; OSTEONECTIN; OSTEOPONTIN; PLECKSTRIN; PROTEASE SERINE 11; PROTEIN PLEKHB1; PROTEINASE; PROTEOGLYCAN; UNCLASSIFIED DRUG;

ACCURACY; ADULT; AGED; ANGIOGENESIS; ARTICLE; ASTROCYTOMA; CELL ADHESION; CELL INFILTRATION; CELL INVASION; CHILD; CLINICAL ARTICLE; DISEASE MARKER; FEMALE; GENE EXPRESSION REGULATION; GENE IDENTIFICATION; GLIOBLASTOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; NUCLEOTIDE SEQUENCE; PILOCYTIC ASTROCYTOMA; POSTERIOR FOSSA; PRIORITY JOURNAL; PROCESS MODEL; PROTEIN DEGRADATION; REAL TIME POLYMERASE CHAIN REACTION; SUPPRESSION SUBTRACTIVE HYBRIDIZATION; UNINDEXED SEQUENCE;

AGED; ASTROCYTOMA; BRAIN NEOPLASMS; CHILD, PRESCHOOL; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, NEOPLASM; GLIOBLASTOMA; HUMANS; MALE; NUCLEIC ACID HYBRIDIZATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, NEOPLASM; SUBTRACTION TECHNIQUE; TUMOR MARKERS, BIOLOGICAL;

EUKARYOTA;

EID: 33646594731     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1209305     Document Type: Article

References (35)

1. Bellail AC, Hunter SB, Brat DJ, Tan C, Van Meir EG. (2004). Int J Biochem Cell Biol 36: 1046-1069.
2. Bonnet F, Perin JP, Maillet P, Jolles P, Alliel PM. (1992). Biochem J 288(Part 2): 565-569.
3. Caskey LS, Fuller GN, Bruner JM, Yung WK, Sawaya RE, Holland EC et al. (2000). Histol Histopathol 15: 971-981.
4. Castellani P, Borsi L, Carnemolla B, Biro A, Dorcaratto A, Viale GL et al. (2002). Am J Pathol 161: 1695-1700.
5. Charbonnier F, Perin JP, Mattei MG, Camuzat A, Bonnet F, Gressin L et al. (1998). Genomics 48: 377-380.
6. Chomczynski P, Sacchi N. (1987). Anal Biochem 162: 156-159.
7. Coppola D, Szabo M, Boulware D, Muraca P, Alsarraj M, Chambers AF et al. (2004). Clin Cancer Res 10: 184-190.
8. Diatchenko L, Lau YF, Campbell AP, Chenchik A, Moqadam F, Huang B et al. (1996). Proc Natl Acad Sci USA 93: 6025-6030.
9. Edgell CJ, BaSalamah MA, Marr HS. (2004). Int Rev Cytol 236: 101-122.
10. Eikmans M, Baelde HJ, Hagen EC, Paul LC, Eilers PH, De Heer E et al. (2003). J Am Soc Nephrol 14: 899-907.
11. Freije WA, Castro-Vargas FE, Fang Z, Horvath S, Cloughesy T, Liau LM et al. (2004). Cancer Res 64: 6503-6510.
12. Gutmann DH, Hedrick NM, Li J, Nagarajan R, Perry A, Watson MA. (2002). Cancer Res 62: 2085-2091.
13. Hunter S, Young A, Olson J, Brat DJ, Bowers G, Wilcox JN et al. (2002). J Neuropathol Exp Neurol 61: 275-281.
14. Khatua S, Peterson KM, Brown KM, Lawlor C, Santi MR, LaFleur B et al. (2003). Cancer Res 63: 1865-1870.
15. Kleihues P, Cavenee WK. (2000). World Health Organization classification of tumors of the nervous system. IARC/WHO: Lyon.
16. Kumazaki T, Mitsui Y, Hamada K, Sumida H, Nishiyama M. (1999). J Cell Sci 112(Part 10): 1449-1453.
17. Lal A, Lash AE, Altschul SF, Velculescu V, Zhang L, McLendon RE et al. (1999). Cancer Res 59: 5403-5407.
18. Lam P, Sian Lim K, Mei Wang S, Hui KM. (2005). Mol Ther 12: 144-152.
19. Markert JM, Fuller CM, Gillespie GY, Bubien JK, McLean LA, Hong RL et al. (2001). Physiol Genomics 5: 21-33.
20. Mischel PS, Cloughesy TF, Nelson SF. (2004). Nat Rev Neurosci 5: 782-792.
21. Mittler MA, Walters BC, Stopa EG. (1996). J Neurosurg 85: 1091-1094.
22. Nigro JM, Misra A, Zhang L, Smirnov I, Colman H, Griffin C et al. (2005). Cancer Res 65: 1678-1686.
23. Pfaffl MW. (2001). Nucleic Acids Res 29: e45.
24. Rickman DS, Bobek MP, Misek DE, Kuick R, Blaivas M, Kurnit DM et al. (2001). Cancer Res 61: 6885-6891.
25. Rittling SR, Chambers AF. (2004). Br J Cancer 90: 1877-1881.
26. Rocchi P, Muracciole X, Fina F, Mulholland DJ, Karsenty G, Palmari J et al. (2004). Oncogene 23: 9111-9119.
27. Saitoh Y, Kuratsu J, Takeshima H, Yamamoto S, Ushio Y. (1995). Lab Invest 72: 55-63.
28. Sallinen SL, Sallinen PK, Haapasalo HK, Helin HJ, Helen PT, Schraml P et al. (2000). Cancer Res 60: 6617-6622.
29. Shen M, Kawamoto T, Yan W, Nakamasu K, Tamagami M, Koyano Y et al. (1997). Biochem Biophys Res Commun 236: 294-298.
30. Tanwar MK, Gilbert MR, Holland EC. (2002). Cancer Res 62: 4364-4368.
31. Tuck AB, Arsenault DM, O'Malley FP, Hota C, Ling MC, Wilson SM et al. (1999). Oncogene 18: 4237-4246.
32. Tuck AB, Hota C, Wilson SM, Chambers AF. (2003). Oncogene 22: 1198-1205.
33. van den Boom J, Wolter M, Kuick R, Misek DE, Youkilis AS, Wechsler DS et al. (2003). Am J Pathol 163: 1033-1043.
34. Wai PY, Kuo PC. (2004). J Surg Res 121: 228-241.
35. Wong KK, Chang YM, Tsang YT, Perlaky L, Su J, Adesina A et al. (2005). Cancer Res 65: 76-84.